サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1642589

再生医療の市場レポート：タイプ別、用途別、エンドユーザー別、地域別、2025年～2033年

Regenerative Medicine Market Report by Type, Application, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 125 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
再生医療の市場レポート：タイプ別、用途別、エンドユーザー別、地域別、2025年～2033年
出版日: 2025年01月18日
発行: IMARC
ページ情報: 英文 125 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の再生医療の市場規模は、2024年に267億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに1,304億米ドルに達し、2025年から2033年にかけて19.15%の成長率（CAGR）を示すと予測しています。移植拒絶反応の懸念の増加、整形外科疾患に対する再生療法への需要の高まり、歯科再生の増加、創傷治癒における薬物使用の増加は、市場成長を促進する要因の一部です。

再生医療は、損傷した組織や臓器の修復に焦点を当てた有望な生物医学分野です。再生医療は、骨、軟骨、血管、重要な臓器の再生を刺激するために、実験室で培養された幹細胞を利用し、安全に体内に移植するものです。この多次元的なアプローチは、免疫調節や組織工学的手法を含む細胞再生療法や無細胞再生療法を包含しています。組織修復にとどまらず、再生医療はアルツハイマー病、パーキンソン病、心血管疾患（CVDs）、骨粗鬆症、脊髄損傷などの慢性疾患の治療において計り知れない可能性を秘めています。研究が進むにつれて、患者の生活とヘルスケアの成果を大幅に改善できる革新的な治療への期待が高まっています。

世界市場の主な原動力は高齢化社会の進展です。これに伴い、糖尿病、心臓病、変形性関節症などの慢性疾患の有病率が上昇しており、市場の成長に大きく寄与しています。さらに、幹細胞治療や遺伝子工学の研究が活発化していることも、再生医療における技術革新を後押ししています。組織の再生や修復のために幹細胞やその他の細胞を用いた治療法の利用が拡大していることも、市場を活性化しています。さらに、再生医療の研究開発に対する資金援助や規制支援が、市場に明るい見通しをもたらしています。さらに、バイオテクノロジーの進歩により、より精密で効果的な再生治療が可能になり、市場を強化しています。さらに、再生治療の選択肢に対する患者の意識の高まりが市場を後押ししています。

再生医療市場傾向 / 促進要因：

がん治療における製品需要の増加

がん治療における製品需要の増加が市場を活性化しています。制御不能な細胞増殖を特徴とするがんは、しばしば組織の損傷につながりますが、これは再生療法によって対処することができます。再生医療は、がんや化学療法のような治療の副作用によって損傷した組織を修復できる標的治療の開発を可能にします。従来のがん治療の衰弱させる副作用を最小限に抑え、患者の全体的な生活の質を高めることを目的としています。これらの技術は腫瘍微小環境の調節に役立ち、がんの進行を抑制する可能性があります。また、治療中に影響を受けた免疫細胞や組織を修復することで、新たながん免疫療法を補完することもできます。活発な調査と臨床試験は、様々ながん種における再生療法の可能性を探り、市場の成長を促進しています。再生療法ががん治療に革命をもたらす可能性があることから、研究開発への投資が集まっています。がんの有病率の上昇と、より効果的で患者に優しい治療の追求は、がん治療における再生医療への需要を煽り、市場の拡大に大きく寄与しています。

免疫療法の急速な進歩

免疫療法の急速な進歩が市場を牽引しています。再生医療のサブセットである免疫療法は、がんや自己免疫疾患などの疾患と闘うために身体の免疫系を利用します。CAR-T細胞療法や免疫チェックポイント阻害剤のような免疫療法は、がん細胞を認識して闘う身体の能力を強化することにより、がん治療に革命をもたらしました。免疫療法の動向は、より個別化された治療アプローチを可能にし、プレシジョン・メディシンのトレンドに合致しています。免疫療法は、化学療法や放射線療法のような従来の治療法よりも重篤な副作用が少ないことが多く、患者の予後を改善します。研究者たちは、治療効果を高めるために免疫療法を再生アプローチと組み合わせることを模索しており、再生医療の範囲を拡大しています。免疫療法の最適化に焦点を当てた臨床試験や調査研究は、この分野の技術革新を推進しています。免疫療法は、自己免疫疾患、感染症、臓器移植など、がん以外への応用も研究されています。免疫療法が疾病管理を一変させる可能性があることから、研究開発には多額の投資が行われています。免疫療法に対する患者の支持と認知度の向上が、免疫療法の採用と市場成長に寄与しています。

美容外科と美容整形における幅広い製品用途

美容整形や美容分野での幅広い製品用途は、この市場セグメントの成長を支える原動力となっています。脂肪由来幹細胞治療を含む再生療法は、乳房再建や顔の若返りなどの施術における自然な組織増強のために使用されます。血小板を豊富に含む血漿（PRP）療法や幹細胞を用いた治療など、革新的なアンチエイジング治療を提供し、若々しい外見を求める人々にアピールしています。再生技術は、手術や事故、怪我による瘢痕の見た目を最小限に抑え、審美的な結果を高めるために採用されています。幹細胞ベースの再生療法は毛髪再生に利用され、脱毛やハゲの悩みに対処します。低侵襲の美容再生手技の台頭は、回復時間の短縮と傷跡の軽減を求める患者にアピールしています。再生美容の需要は成長し続けており、この分野への投資と技術革新を引き寄せています。再生美容施術における高い患者満足度と良好な結果は、口コミによる紹介と市場拡大を促進します。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の再生医療市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 幹細胞療法
    • 市場動向
    • 市場予測
  • 生体材料
    • 市場動向
    • 市場予測
  • 組織工学
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：用途別

  • 骨移植代替品
    • 市場動向
    • 市場予測
  • 骨関節疾患
    • 市場動向
    • 市場予測
  • 皮膚科
    • 市場動向
    • 市場予測
  • 心臓血管
    • 市場動向
    • 市場予測
  • 中枢神経系
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 専門クリニック
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Allergan PLC（AbbVie Inc.）
    • Amgen Inc.
    • Baxter International Inc.
    • BD（Becton, Dickinson and Company）
    • Integra Lifesciences Holdings Corporation
    • Medtronic Plc
    • Mimedx Group Inc.
    • Novartis AG
    • Osiris Therapeutics Inc.（Smith & Nephew plc）
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Regenerative Medicine Market: Major Drivers and Challenges
  • Figure 2: Global: Regenerative Medicine Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Regenerative Medicine Market: Breakup by Type (in %), 2024
  • Figure 4: Global: Regenerative Medicine Market: Breakup by Application (in %), 2024
  • Figure 5: Global: Regenerative Medicine Market: Breakup by End User (in %), 2024
  • Figure 6: Global: Regenerative Medicine Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Regenerative Medicine Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 8: Global: Regenerative Medicine (Stem Cell Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Regenerative Medicine (Stem Cell Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Regenerative Medicine (Biomaterial) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Regenerative Medicine (Biomaterial) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Regenerative Medicine (Tissue Engineering) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Regenerative Medicine (Tissue Engineering) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Regenerative Medicine (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Regenerative Medicine (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Regenerative Medicine (Bone Graft Substitutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Regenerative Medicine (Bone Graft Substitutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Regenerative Medicine (Osteoarticular Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Regenerative Medicine (Osteoarticular Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Regenerative Medicine (Dermatology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Regenerative Medicine (Dermatology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Regenerative Medicine (Cardiovascular) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Regenerative Medicine (Cardiovascular) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Regenerative Medicine (Central Nervous System) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Regenerative Medicine (Central Nervous System) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Regenerative Medicine (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Regenerative Medicine (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Regenerative Medicine (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Regenerative Medicine (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Regenerative Medicine (Specialty Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Regenerative Medicine (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Regenerative Medicine (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Regenerative Medicine (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: North America: Regenerative Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: North America: Regenerative Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: United States: Regenerative Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: United States: Regenerative Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Canada: Regenerative Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Canada: Regenerative Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Asia Pacific: Regenerative Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Asia Pacific: Regenerative Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: China: Regenerative Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: China: Regenerative Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Japan: Regenerative Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Japan: Regenerative Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: India: Regenerative Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: India: Regenerative Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: South Korea: Regenerative Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: South Korea: Regenerative Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Australia: Regenerative Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Australia: Regenerative Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Indonesia: Regenerative Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Indonesia: Regenerative Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Others: Regenerative Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Others: Regenerative Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Europe: Regenerative Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Europe: Regenerative Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Germany: Regenerative Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Germany: Regenerative Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: France: Regenerative Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: France: Regenerative Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: United Kingdom: Regenerative Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: United Kingdom: Regenerative Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Italy: Regenerative Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Italy: Regenerative Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Spain: Regenerative Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Spain: Regenerative Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Russia: Regenerative Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Russia: Regenerative Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Regenerative Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Regenerative Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Latin America: Regenerative Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Latin America: Regenerative Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Brazil: Regenerative Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Brazil: Regenerative Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Mexico: Regenerative Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Mexico: Regenerative Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Others: Regenerative Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Others: Regenerative Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Middle East and Africa: Regenerative Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Middle East and Africa: Regenerative Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Global: Regenerative Medicine Industry: SWOT Analysis
  • Figure 83: Global: Regenerative Medicine Industry: Value Chain Analysis
  • Figure 84: Global: Regenerative Medicine Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Regenerative Medicine Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Regenerative Medicine Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Regenerative Medicine Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Regenerative Medicine Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Regenerative Medicine Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Regenerative Medicine Market Structure
  • Table 7: Global: Regenerative Medicine Market: Key Players
目次
Product Code: SR112024A2517

The global regenerative medicine market size reached USD 26.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 130.4 Billion by 2033, exhibiting a growth rate (CAGR) of 19.15% during 2025-2033. The increasing transplant rejection concerns, the rising demand for regenerative therapies for orthopedic conditions, the growing dental regeneration, and the escalating medicine use in wound healing are some of the factors propelling the market growth.

Regenerative medicine represents a promising biomedical science field focused on restoring damaged tissues and organs. It harnesses laboratory-cultivated stem cells, safely transplanted into the body to stimulate the regeneration of bones, cartilage, blood vessels, and vital organs. This multidimensional approach encompasses cellular and acellular regenerative therapies, including immunomodulation and tissue engineering techniques. Beyond tissue repair, regenerative medicine holds immense potential in treating chronic ailments like Alzheimer's, Parkinson's, cardiovascular diseases (CVDs), osteoporosis, and spinal cord injuries. As research advances, it offers hope for transformative treatments that could significantly improve patients' lives and healthcare outcomes.

The global market is majorly driven by the increasing aging population. In line with this, the rising prevalence of chronic diseases such as diabetes, heart disease, and osteoarthritis is significantly contributing to the market growth. Furthermore, the growing research in stem cell therapies and genetic engineering drives innovation in regenerative medicine. The escalating use of stem cells and other cell-based therapies for tissue regeneration and repair is also catalyzing the market. Moreover, the funding and regulatory support for regenerative medicine research and development are creating a positive outlook for the market. Besides, the advancements in biotechnology enable more precise and effective regenerative therapies, bolstering the market. Additionally, the increasing awareness among patients about regenerative treatment options is providing a boost to the market.

Regenerative Medicine Market Trends/Drivers:

Increasing product demand in cancer treatment

The increasing product demand in cancer treatment is catalyzing the market. Cancer, characterized by uncontrolled cell growth, often leads to tissue damage, which can be addressed through regenerative therapies. Regenerative medicine allows for the development of targeted therapies that can repair damaged tissues caused by cancer or side effects of treatments like chemotherapy. It aims to minimize traditional cancer treatment's debilitating side effects, enhancing patients' overall quality of life. These techniques can help modulate the tumor microenvironment, potentially inhibiting cancer progression. It also complements emerging cancer immunotherapies by repairing immune cells or tissues affected during treatment. Robust research and clinical trials explore the potential of regenerative therapies in various cancer types, fostering market growth. The potential for regenerative therapies to revolutionize cancer treatment attracts investment in research and development. The rising prevalence of cancer and the pursuit of more effective, patient-friendly treatments fuel the demand for regenerative medicine in cancer care, contributing significantly to the market's expansion.

Rapid advancements in immunotherapy

Rapid advancements in immunotherapy are propelling the market. Immunotherapy, a subset of regenerative medicine, harnesses the body's immune system to fight diseases, including cancer and autoimmune disorders. Immunotherapies like CAR-T cell therapy and immune checkpoint inhibitors have revolutionized cancer treatment by enhancing the body's ability to recognize and combat cancer cells. Advances in immunotherapy enable more personalized treatment approaches, aligning with the trend toward precision medicine. They often have fewer severe side effects than traditional treatments like chemotherapy and radiation therapy, improving patient outcomes. Researchers explore combining immunotherapies with regenerative approaches to enhance treatment efficacy, expanding the scope of regenerative medicine. Robust clinical trials and research initiatives focus on optimizing immunotherapies, driving innovation in the field. Immunotherapies are being investigated for applications beyond cancer, including autoimmune diseases, infectious diseases, and organ transplantation. The potential of immunotherapy to transform disease management attracts substantial investments in research and development. Increasing patient advocacy and awareness of immunotherapies contribute to their adoption and market growth.

Widespread product applications in cosmetic surgery and aesthetics

The widespread product applications in cosmetic surgery and aesthetics are a driving force behind the growth of this market segment. Regenerative therapies, including adipose-derived stem cell treatments, are used for natural tissue augmentation in procedures like breast reconstruction and facial rejuvenation. They offer innovative anti-aging treatments, such as platelet-rich plasma (PRP) therapy and stem cell-based interventions, appealing to individuals seeking youthful appearances. Regenerative techniques are employed to minimize the appearance of scars resulting from surgeries, accidents, or injuries, enhancing aesthetic outcomes. Stem cell-based regenerative therapies are utilized for hair restoration, addressing hair loss and baldness concerns. The rise of minimally invasive aesthetic regenerative procedures appeals to patients seeking shorter recovery times and reduced scarring. The demand for regenerative aesthetics continues to grow, attracting investments and innovations in the field. High patient satisfaction rates and positive outcomes in regenerative aesthetic procedures drive word-of-mouth referrals and market expansion.

Regenerative Medicine Industry Segmentation:

Breakup by Type:

Stem Cell Therapy

Biomaterial

Tissue Engineering

Others

Stem cell therapy dominates the market

Stem cell therapy harnesses the unique regenerative properties of stem cells to repair and replace damaged or dysfunctional tissues and organs. It offers diverse therapeutic applications, including orthopedics, cardiology, neurology, and oncology. This versatility attracts investment and research, expanding its market presence. Clinical trials and case studies demonstrate the effectiveness of stem cell therapies in treating previously incurable conditions, boosting patient and physician confidence. With the global population aging, there's an increasing prevalence of age-related diseases and degenerative conditions, driving demand for regenerative treatments.

Furthermore, the regulatory bodies recognize stem cell therapies' potential, resulting in streamlined approvals and guidelines, further encouraging market growth. Patients seeking alternatives to conventional treatments are turning to stem cell therapies for better outcomes and reduced side effects. The potential of stem cell therapies attracts investments, fostering research and development and expanding accessibility. Advances in stem cell isolation, culturing, and delivery methods improve treatment efficacy, expanding their applications. Stem cell therapy providers are expanding their reach globally, making these treatments available to a wider patient population.

Breakup by Application:

Bone Graft Substitutes

Osteoarticular Diseases

Dermatology

Cardiovascular

Central Nervous System

Others

Dermatology dominates the market

Dermatology is a vital application within regenerative medicine, focusing on the restoration and regeneration of skin tissues. It addresses a wide spectrum of dermatological concerns, ranging from scar reduction and wound healing to treating skin disorders and aging-related skin conditions.

Regenerative approaches in dermatology include using stem cells, growth factors, and tissue engineering techniques, offering patients innovative and minimally invasive solutions for achieving healthier, more youthful, and blemish-free skin. This segment is gaining traction due to the growing demand for cosmetic and aesthetic enhancements and the need for effective treatments for various skin ailments, ultimately contributing to the overall growth of the regenerative medicine market.

Breakup by End User:

Hospitals

Specialty Clinics

Others

Hospitals dominate the market

Hospitals serve as prominent end users within the regenerative medicine market, playing a pivotal role in the adoption and growth of regenerative therapies. They serve as hubs for advanced medical care and are integral for several reasons. Hospitals provide the infrastructure and expertise necessary for conducting complex regenerative procedures, such as organ transplants and stem cell therapies, ensuring patient safety and optimal outcomes. They also facilitate clinical trials and research initiatives, allowing for the development and testing innovative regenerative treatments.

Furthermore, hospitals are key in delivering regenerative therapies to patients, especially acute injuries, chronic diseases, or conditions requiring specialized medical attention. As healthcare institutions embrace regenerative medicine, hospitals remain central in its expansion, offering hope and cutting-edge treatments to a diverse patient population.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America represents a significant region in the regenerative medicine market, driving growth through several key factors. The region's advanced healthcare infrastructure, robust research and development capabilities, and high healthcare expenditure contribute to the adoption of regenerative therapies. It is home to numerous renowned research institutions, biotechnology companies, and academic centers specializing in regenerative medicine, fostering innovation and clinical advancements.

Regulatory support and well-defined approval processes in countries like the United States accelerate the introduction of regenerative treatments to the market. A growing aging population with age-related conditions also fuels the demand for regenerative solutions. Moreover, a strong focus on addressing chronic diseases, sports injuries, and aesthetic concerns further propels the use of regenerative therapies in North America. These factors collectively position North America as a prominent growth driver in the regenerative medicine sector.

Competitive Landscape:

Top companies are strengthening the market through innovation, strategic partnerships, and extensive research. They invest heavily in research and development, pushing the boundaries of regenerative medicine, uncovering new therapies, and expanding treatment options. They conduct large-scale clinical trials to demonstrate the safety and efficacy of regenerative therapies, gaining regulatory approvals and boosting market confidence. Top companies develop a diverse portfolio of regenerative products, catering to various medical conditions and applications, from orthopedics to oncology. These companies expand globally, ensuring wider access to their therapies and increasing market reach. Partnerships with research institutions, healthcare providers, and pharmaceutical companies facilitate knowledge sharing and the development of novel therapies. They navigate complex regulatory landscapes, ensuring their therapies meet stringent safety and quality standards instilling trust in healthcare professionals and patients. Top companies engage in patient advocacy and education, raising awareness about the benefits of regenerative medicine, thus driving demand. Their track record of success attracts investments, enabling further research and development of groundbreaking therapies.

The report has provided a comprehensive analysis of the competitive landscape in the regenerative medicine market. Detailed profiles of all major companies have also been provided.

Allergan PLC (AbbVie Inc.)

Amgen Inc.

Baxter International Inc.

BD (Becton, Dickinson and Company)

Integra Lifesciences Holdings Corporation

Medtronic plc

Mimedx Group Inc.

Novartis AG

Osiris Therapeutics Inc. (Smith & Nephew plc)

Thermo Fisher Scientific Inc

Key Questions Answered in This Report:

  • How has the global regenerative medicine market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global regenerative medicine market?
  • What is the impact of each driver, restraint, and opportunity on the global regenerative medicine market?
  • What are the key regional markets?
  • Which countries represent the most attractive regenerative medicine market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the regenerative medicine market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the regenerative medicine market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the regenerative medicine market?
  • What is the competitive structure of the global regenerative medicine market?
  • Who are the key players/companies in the global regenerative medicine market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Regenerative Medicine Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Stem Cell Therapy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Biomaterial
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Tissue Engineering
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Bone Graft Substitutes
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Osteoarticular Diseases
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Dermatology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cardiovascular
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Central Nervous System
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Specialty Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Allergan PLC (AbbVie Inc.)
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amgen Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Baxter International Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 BD (Becton, Dickinson and Company)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Integra Lifesciences Holdings Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Medtronic Plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Mimedx Group Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Novartis AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Osiris Therapeutics Inc. (Smith & Nephew plc)
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Thermo Fisher Scientific Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis